Alanlı R, Kucukay MB. Evaluation of Novel Markers in Predicting Nonalcoholic Fatty Liver: Uric Acid–High-Density Lipoprotein Ratio. Lokman Hekim Health Sci. 2023 ;3(1):16-21. doi: 10.14744/lhhs.2022.90001.
Alanlı R, Kucukay MB. Evaluation of Novel Markers in Predicting Nonalcoholic Fatty Liver: Uric Acid–High-Density Lipoprotein Ratio. Lokman Hekim Health Sci. 2023;3(1):16-21. doi: 10.14744/lhhs.2022.90001
Alanlı, R., & Kucukay, M. B. (2023). Evaluation of Novel Markers in Predicting Nonalcoholic Fatty Liver: Uric Acid–High-Density Lipoprotein Ratio. Lokman Hekim Health Sciences, 3(1), 16-21. https://doi.org/10.14744/lhhs.2022.90001
Alanlı, R., and M. B. Kucukay. "Evaluation of Novel Markers in Predicting Nonalcoholic Fatty Liver: Uric Acid–High-Density Lipoprotein Ratio." Lokman Hekim Health Sciences, vol. 3, no. 1, 2023, pp. 16-21. https://doi.org/10.14744/lhhs.2022.90001.
Alanlı, R., M. B. Kucukay. 2023. "Evaluation of Novel Markers in Predicting Nonalcoholic Fatty Liver: Uric Acid–High-Density Lipoprotein Ratio." Lokman Hekim Health Sciences 3, no. 1: 16-21. https://doi.org/10.14744/lhhs.2022.90001.